您当前所在位置:首页 > 关于我们 > 新品上市
序号 标题 次数 作者 发布时间
76861 sulfo-SPDB-DGN462,用于提高化合物的水溶性和稳定性 156 WYQ 2024-12-19
76862 Fmoc-Gly-Gly-Phe-Gly-OH, ADC试剂 131 kx 2024-12-19
76863 1342211-31-7,MC-Val-Ala-OH,马来酰亚胺基己酰-L-缬氨酰-L-丙氨酸,ADC连接子多肽 158 kx 2024-12-19
76864 MA-PEG4-VC-PAB-DMAE-PNU159682(CAS号:2259318-52-8) 110 WYQ 2024-12-19
76865 MC-vc-PAB-C6-a-amanitin,一种抗体药物偶联物(ADC) 117 WYQ 2024-12-19
76866 cas:690632-55-4,N-Succinimidyloxycarbonylpropyl Methanethiosulfonate 72 wyh 2024-12-19
76867 VC-MMAF(CAS号:863971-17-9) 109 WYQ 2024-12-19
76868 cas:159857-70-2 MC-Val-Cit-Doxorubicin-ADC抗体偶联药物 93 zyl 2024-12-19
76869 2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 95 kx 2024-12-19
76870 cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP 108 zyl 2024-12-19
76871 perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate 130 wyh 2024-12-19
76872 MC -Val-Cit, ADC试剂 162 kx 2024-12-19
76873 cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate 172 wyh 2024-12-19
76874 cas:159857-81-5 Mc-Val-Cit-PABC-PNP 119 zyl 2024-12-19
76875 MC-PEG4-va-PAB-Exatecan, ADC试剂 180 kx 2024-12-19
76876 cas:2101206-44-2 PY-DS-DMBUT-OPFP 133 zyl 2024-12-19
76877 Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate 75 wyh 2024-12-19
76878 SMCC-DM4(CAS号:1228105-52-9) 108 WYQ 2024-12-19
76879 NHS ester-PEG4-VC-PAB-Dxd, ADC试剂 261 kx 2024-12-19
76880 cas:53053-08-0,4-azidobenzoic acid N-hydroxysuccinimide ester 87 wyh 2024-12-19
76881 N3-Linker-Gefitinib,Gefitinib本身具有*肿瘤活性 131 WYQ 2024-12-19
76882 Boc-Val-Cit-OH的介绍 109 zyl 2024-12-19
76883 mDPR-Val-Ala-PAB-MMAE, ADC试剂 130 kx 2024-12-19
76884 Boc-Val-Ala-PAB-OC2H5 | ADC Linker 117 zyl 2024-12-19
76885 cas:2259318-56-2,DBCO-PEG4-VC-PAB-DMAE-PNU159682, ADC试剂 122 kx 2024-12-19
76886 Mc-Dexamethasone,CAS号:1618096-56-2 134 WYQ 2024-12-19
76887 N3-PEG4-YPYDVPDYA-Doxorubicin,抗体偶联药物(ADC)的一部分 158 WYQ 2024-12-19
76888 DBCO-PEG4-VA-PAB-EDA-N-Ac-Calicheamicin,ADC定制 167 kx 2024-12-19
76889 N3-PEG4-DYKDDDD-Doxorubicin,抗体偶联药物(ADC)的一部分 135 WYQ 2024-12-19
76890 Azide-hex-vc-PAB-EDA-Biotin的介绍 139 zyl 2024-12-19
76891 Fmoc-PEG4-Val-Ala-PAB-PNP,具有类似的可降解性、生物相容性和定向运输特性 145 WYQ 2024-12-19
76892 DBCO-PEG4-vc-PAB (PEG2)- Duocarmycin SA,ADC定制 139 kx 2024-12-19
76893 Mal-Ala-Ala-PAB-PNP的介绍 171 zyl 2024-12-19
76894 Fmoc-PEG4-Val-Ala-PAB,合成抗体偶联药物(ADC) 111 WYQ 2024-12-19
76895 BODIPY-erythromycin,ADC定制 148 kx 2024-12-19
76896 MA-PEG4-Glu-Val-Cit-PAB-PNP 132 zyl 2024-12-19
76897 Boc-PEG4-Val-Ala-PAB-PNP,用于合成抗体偶联药物(ADC) 104 WYQ 2024-12-19
76898 Mc-Phe-Lys(Boc)-PAB-ADC分子 137 zyl 2024-12-19
76899 MC-GGFG-Dxd, ADC试剂 553 kx 2024-12-19
76900 Fmoc-Arg(boc)2-PAB-PNP-ADC抗体偶联药物 104 zyl 2024-12-19
76901 DBCO-PEG4-AcBu-Calicheamicin, ADC试剂 95 kx 2024-12-19
76902 Azido-PEG4-Val-Ala-PAB的介绍 92 zyl 2024-12-19
76903 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,ADC定制 76 wyh 2024-12-19
76904 OH-Glu-VC-PAB-MMAE, ADC试剂 150 kx 2024-12-19
76905 cas:663599-10-8,2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate,ADC定制 95 wyh 2024-12-19
库存查询